Cargando…

Iron oxide nanoparticles for biomedical applications : synthesis, functionalization and application /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Mahmoudi, Morteza, 1979-, Laurent, Sophie, 1967-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cambridge, MA : Elsevier, [2018]
Colección:Metal oxides series.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • Iron Oxide Nanoparticles for Biomedical Applications: Synthesis, Functionalization and Application
  • Copyright
  • Contents
  • List of Contributors
  • Editors' Biography
  • Series Editor's Biography
  • Preface to the Series
  • Part 1: Iron Oxide Nanoparticles
  • Chapter 1: Metal Oxide Particles and Their Prospects for Applications
  • 1.1. Magnetic Metal Oxides
  • 1.2. Metal Oxides With Photoluminescence Properties
  • 1.3. Metal Oxides in Electronics, Catalysis, Gas Sensors and Energy Technologies
  • 1.3.1. Metal Oxide in Electronics
  • 1.3.2. Metal Oxides as Catalysts1.3.3. Metal Oxides in Gas Sensing
  • 1.3.4. Metal Oxide in Energy Technologies
  • 1.4. Metal Oxides in Biomedical Applications
  • 1.4.1. MRI and Cancer Treatment
  • 1.4.2. Antibacterial Properties
  • 1.4.3. Biomedical Implant
  • References
  • Further Reading
  • Chapter 2: Iron Oxide Nanoparticles for Biomedical Applications: Synthesis, Functionalization, and Application
  • 2.1. Iron Nanoparticles: Advantages and Limitations for Biomedical Applications
  • 2.1.1. Context
  • 2.1.2. Diagnosis
  • 2.1.3. Therapy
  • 2.2. Synthesis of Iron Oxide Nanoparticles Aimed for Biomedical Applications2.2.1. Overview
  • 2.2.2. Understanding the Nanoparticles Formation
  • 2.2.2.1. General Principle
  • 2.2.2.2. Nucleation/Growth Principle-LaMer Theory
  • 2.2.3. Iron Oxide NPs Synthesis by Wet Chemical Methods
  • 2.2.3.1. Main Wet Chemical Synthesis Methods
  • 2.2.3.2. Thermal Decomposition Synthesis
  • Control of the Composition
  • Size Control
  • Morphology Control: The Case of Cubes
  • 2.2.4. Conclusion
  • 2.3. Stabilization of the Nanosystems
  • 2.3.1. Polymers
  • 2.3.2. Dendrimers2.3.2.1. Dendrimer-Stabilized NPs (DSNPs)
  • 2.3.2.2. Dendrimer-Assembled NPs (DANPs)
  • 2.3.2.3. Dendronized Nanoparticles
  • 2.3.3. Nonpolymeric Surface
  • 2.4. Methods of IONPs Functionalization for Biomedical Applications
  • 2.4.1. Functionalization Strategies as a Function of the NPs Synthesis Method
  • 2.4.2. Interaction of Molecules With the Surface of Iron Oxide NPs: Importance of Anchoring Groups
  • References
  • Part 2: Biomedical Applications
  • Chapter 3: Protein Corona: The Challenge at the Nanobiointerfaces
  • 3.1. Introduction
  • 3.2. The Protein Corona3.3. Hard Versus Soft Corona
  • 3.4. Reversible Versus Irreversible Interactions Between NPs and Proteins
  • References
  • Chapter 4: Nanocytotoxicity
  • 4.1. Introduction
  • 4.2. Cytotoxicity
  • 4.3. Superparamagnetic Iron Oxide Nanoparticles
  • References
  • Chapter 5: Magnetic Particle Imaging (MPI)
  • 5.1. Introduction
  • 5.2. Superparamagnetic Iron Oxide Nanoparticles for MPI
  • 5.3. Size and Homogeneity
  • 5.4. Iron Oxide Nanoparticle Coatings
  • References